BNTX vs. NVO
BNTX (BioNTech SE) and NVO (Novo Nordisk A/S) are both stocks. Both are in the Healthcare sector — BNTX in Biotechnology, NVO in Drug Manufacturers - General. Over the past 5 years, BNTX returned -17.42%/yr vs 2.96%/yr for NVO. At a 0.23 correlation, their price movements are largely independent.
Performance
BNTX vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BNTX achieves a -5.95% return, which is significantly higher than NVO's -10.58% return.
BNTX
- 1D
- 3.93%
- 1M
- -4.40%
- YTD
- -5.95%
- 6M
- -6.73%
- 1Y
- -15.10%
- 3Y*
- -6.57%
- 5Y*
- -17.42%
- 10Y*
- —
NVO
- 1D
- 2.69%
- 1M
- -6.47%
- YTD
- -10.58%
- 6M
- -9.53%
- 1Y
- -41.56%
- 3Y*
- -15.73%
- 5Y*
- 2.96%
- 10Y*
- 7.06%
BNTX vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BNTX BioNTech SE | -5.95% | -16.45% | 7.97% | -29.74% | -40.40% | 216.24% | 140.61% | 105.33% |
NVO Novo Nordisk A/S | -10.58% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 12.24% |
Correlation
The correlation between BNTX and NVO is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Oct 10, 2019 | 0.23 |
The correlation between BNTX and NVO shifts across timeframes, from 0.21 (3 years) to 0.38 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
BNTX:
$22.64B
NVO:
$195.56B
BNTX:
-€5.14
NVO:
DKK 27.42
BNTX:
6.78
NVO:
3.86
BNTX:
1.05
NVO:
6.23
BNTX:
€2.80B
NVO:
DKK 327.80B
BNTX:
€2.05B
NVO:
DKK 268.30B
BNTX:
-€815.04M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BNTX vs. NVO — Risk / Return Rank
BNTX
NVO
BNTX vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioNTech SE (BNTX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BNTX | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.43 | ||
| Sortino ratioReturn per unit of downside risk | +0.72 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 0.86 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.51 | -0.76 | +0.25 |
| Martin ratioReturn relative to average drawdown | -1.04 | -1.11 | +0.07 |
Loading charts...
Drawdowns
BNTX vs. NVO - Drawdown Comparison
The maximum BNTX drawdown since its inception was -82.08%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for BNTX and NVO.
Loading charts...
Drawdown Indicators
| BNTX | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.08% | -74.70% | -7.38% |
Max Drawdown (1Y)Largest decline over 1 year | -29.71% | -55.03% | +25.32% |
Max Drawdown (3Y)Largest decline over 3 years | -37.35% | -74.70% | +37.35% |
Max Drawdown (5Y)Largest decline over 5 years | -82.08% | -74.70% | -7.38% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -79.52% | -68.06% | -11.46% |
Average DrawdownAverage peak-to-trough decline | -56.23% | -17.78% | -38.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.60% | 37.52% | -22.92% |
Volatility
BNTX vs. NVO - Volatility Comparison
The current volatility for BioNTech SE (BNTX) is 9.62%, while Novo Nordisk A/S (NVO) has a volatility of 10.69%. This indicates that BNTX experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BNTX | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.62% | 10.69% | -1.07% |
Volatility (6M)Calculated over the trailing 6-month period | 34.13% | 38.46% | -4.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 51.88% | -10.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 55.27% | 38.34% | +16.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 76.37% | 32.56% | +43.81% |
Dividends
BNTX vs. NVO - Dividend Comparison
BNTX has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BNTX BioNTech SE | 0.00% | 0.00% | 0.00% | 0.00% | 2.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.10% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
BNTX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between BioNTech SE and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BNTX and NVO have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (10.69%) compared to BNTX (9.62%). In terms of maximum drawdown, BNTX dropped -82.08% vs NVO's -74.70%.
BNTX currently has the higher Sharpe Ratio (-0.37 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BNTX and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer